Finnland -
finnska -
Fimea (Suomen lääkevirasto)
pepcid 10 mg tabletti, kalvopäällysteinen
mcneil / jntl consumer health (finland) oy - famotidine - tabletti, kalvopäällysteinen - 10 mg - famotidiini
Finnland -
finnska -
Fimea (Suomen lääkevirasto)
glypressin 1 mg injektiokuiva-aine ja liuotin, liuosta varten
ferring lÄÄkkeet oy - terlipressin acetate - injektiokuiva-aine ja liuotin, liuosta varten - 1 mg - terlipressiini
Finnland -
finnska -
Fimea (Suomen lääkevirasto)
pepcid duo 10 mg / 165 mg / 800 mg purutabletti
mcneil / jntl consumer health (finland) oy - calcium carbonate, famotidine, magnesium hydroxide - purutabletti - 10 mg / 165 mg / 800 mg - famotidiini
Finnland -
finnska -
Fimea (Suomen lääkevirasto)
glypressin 1 mg injektioneste, liuos
ferring lÄÄkkeet oy - terlipressin acetate - injektioneste, liuos - 1 mg - terlipressiini
Finnland -
finnska -
Fimea (Suomen lääkevirasto)
terlipressin sun 1 mg injektioneste, liuos
sun pharmaceutical industries europe b.v. - terlipressin - injektioneste, liuos - 1 mg - terlipressiini
Evrópusambandið -
finnska -
EMA (European Medicines Agency)
blenrep
glaxosmithkline (ireland) limited - belantamab mafodotin - multiple myeloma - antineoplastiset aineet - blenrep is indicated as monotherapy for the treatment of multiple myeloma in adult patients, who have received at least four prior therapies and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.
